Synthesis, β-adrenoceptor pharmacology and toxicology of S-(−)-1-(4-(2-ethoxyethoxy)phenoxy)-2-hydroxy-3-(2-(3,4-dimethoxyphenyl)ethylamino)propane hydrochloride, a short acting β1-specific antagonist

This publication has 11 references indexed in Scilit:

• ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
  Circulation, 2000
• beta Blockade after myocardial infarction: systematic review and meta regression analysis
  BMJ, 1999
• The effects of a new ultra-short-acting β-adrenergic blocker, ONO-1101, on cardiac function during and after cardiopulmonary bypass
  Surgery Today, 1999
• LK 204–545, a highly selective β1-adrenoceptor antagonist at human β-adrenoceptors
  European Journal of Pharmacology, 1999
• Time Course of a New Ultrashort-Acting β-Adrenoceptor-Blocking Drug, ONO-1101: Comparison with Those of Esmolol and Propranolol by Using the Canine Isolated, Blood-Perfused Heart Preparations
  Journal of Cardiovascular Pharmacology, 1998
• Esmolol, an ultrashort-acting, selective ?1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties
  European Journal of Clinical Pharmacology, 1994
• [(Arylcarbonyl)oxy]propanolamines. 1. Novel .beta.-blockers with ultrashort duration of action
  Journal of Medicinal Chemistry, 1984
• Ultra-short-acting .beta.-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent
  Journal of Medicinal Chemistry, 1982
• Ultra-short-acting .beta.-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function
  Journal of Medicinal Chemistry, 1982
• Computerized graphic methods for determining dissociation constants of agonists, partial agonists, and competitive antagonists in isolated smooth muscle preparations
  Journal of Pharmacological Methods, 1980